Radiation Safety Research Center, Nuclear Technology Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), 2-11-1 Iwado-kita, Komae, Tokyo 201-8511, Japan.
Clinical Department, Southern Urals Biophysics Institute (SUBI), Ozyorskoe Shosse 19, Ozyorsk Chelyabinsk Region, 456780, Ozersk, Russia.
Br J Radiol. 2020 Nov 1;93(1115):20190829. doi: 10.1259/bjr.20190829. Epub 2019 Nov 12.
The International Commission on Radiological Protection (ICRP) has considered for over 60 years that the lens of the eye is among the most radiosensitive tissues, and has recommended dose limits for the lens to prevent occurrence of vision impairing cataracts (VICs). Epidemiological evidence that doses much lower than previously thought produce cataracts led ICRP to recommend reducing dose threshold for VICs and reducing an occupational equivalent dose limit for the lens in 2011, when only a single threshold of 0.5 Gy was recommended. On the basis of epidemiological evidence, ICRP assumed progression of minor opacities into VICs and no dose rate effect. This contrasts with previously recommended separate thresholds for minor opacities and VICs, and for different exposure scenarios. Progression was assumed based on similar risks of cataracts and cataract surgery in Japanese atomic bomb survivors. The absence of dose rate effect derived from the observed similar thresholds for protracted exposures in Chernobyl cleanup workers and in atomic bomb survivors. Since 2011, there has been an increasing body of epidemiological evidence relating to cataracts and other ocular diseases ( glaucoma and macular degeneration), particularly at low doses and low dose rates. This review paper gives an overview of the scientific basis of the 2011 ICRP recommendation, discusses the plausibility of these two assumptions in the light of emerging scientific evidence, and considers the radiosensitivity of the lens among ocular structures.
国际放射防护委员会(ICRP)已经考虑了 60 多年,认为眼睛的晶状体是最敏感的组织之一,并建议对晶状体进行剂量限制,以防止视力受损白内障(VIC)的发生。流行病学证据表明,剂量远低于先前认为的会导致白内障,这促使 ICRP 在 2011 年建议降低 VIC 的剂量阈值,并降低晶状体的职业当量剂量限制,当时仅推荐 0.5Gy 的单一阈值。基于流行病学证据,ICRP 假设轻微混浊向 VIC 进展且不存在剂量率效应。这与之前推荐的轻微混浊和 VIC 的单独阈值以及不同的暴露情况形成对比。进展是基于日本原子弹幸存者白内障和白内障手术的相似风险假设的。没有剂量率效应是源于切尔诺贝利清理人员和原子弹幸存者中观察到的长时间暴露的相似阈值。自 2011 年以来,与白内障和其他眼部疾病(青光眼和黄斑变性)相关的越来越多的流行病学证据不断涌现,特别是在低剂量和低剂量率下。这篇综述文章概述了 2011 年 ICRP 建议的科学依据,根据新出现的科学证据讨论了这两个假设的合理性,并考虑了晶状体在眼部结构中的放射敏感性。